Dr. Rizwan R. Kalwar, MD

Dr. Kalwar practices at Douglas Gardens Hospital in Miami, Florida, part of Miami Jewish Health Systems.

Dr. Kalwar's NPI, 1831488402, was assigned on April 4, 2011. Dr. Kalwar graduated from St. Matthew's University in 2006. Dr. Kalwar holds Florida license ME116518.

Dr. Kalwar's primary practice is Douglas Gardens Hospital, at 5200 NE 2nd Ave, Miami, FL 33137 in Miami-Dade County. The practice phone is (305) 751-8626.

Dr. Kalwar's primary practice is Douglas Gardens Hospital in Miami, Florida, part of Miami Jewish Health Systems. The medical group on file is Florida Post Acute Care Clinicians. Dmand AI also links Dr. Kalwar to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalwar practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kalwar's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Kalwar's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists chronic diabetes, chronic skin ulcer, contact dermatitis, mobility impairment, peripheral vascular disease, skin cyst and varicose veins among the conditions Dr. Kalwar treats.

CMS data shows 4,145 Medicare services from Dr. Kalwar across 12 procedure codes in 2024, for 408 Medicare patients. Medicare paid $489,158 for them.

CMS counts 408 Medicare patients who saw Dr. Kalwar in 2024. The largest group is 85 and over, with 184 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 67% are also on Medicaid. Their average risk score is 3.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalwar's median patient age at 83, with 60% women.

In 2024, Dr. Kalwar wrote 29 Medicare Part D claims for 19 patients. 48% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $3,579 in total drug cost. In 2022, CMS named 63 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kalwar for performance year 2024, reported as part of a group. Dr. Kalwar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 149 procedures of removal of tissue by Dr. Kalwar, more than 89% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 17 general payments to Dr. Kalwar from 2 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $466.

Dr. Kalwar graduated from St. Matthew's University in 2006.

Dr. Kalwar is in network with 3 carriers, including Aetna, Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.